SLC40A1 and idiopathic pulmonary fibrosis: This review synthesizes current findings on the mechanistic interplay between iron homeostasis and macrophage phenotypic switching in IPF and evaluates emerging therapeutic strategies that target iron availability, including iron chelators, ferroportin modulators, and targeted nanocarrier delivery systems.